Maclura pomifera
Species
KNApSAcK Entry
| Organism name | Maclura pomifera |
|---|---|
| Genus | Maclura |
| Family | Moraceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Maclura pomifera |
|---|---|
| Linked NCBI taxonomy ID | 3496 |
| Linked level | species |
Family
| Family in NCBI taxonomy | Moraceae |
|---|---|
| ID | 3487 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | rosids |
|---|---|
| ID | 71275 |
Metabolite list (22)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00004025
|
Artocarpesin
/ 2',4',5,7-Tetrahydroxy-6-(3-methyl-2-butenyl)flavone / 2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one |
CHEMBL1915458
|
1 / 4 / 1 | No. 15 | No. 15 |
|
||
|
C00002586
|
Wighteone
/ Erythrinin B / 5,7,4'-Trihydroxy-6-prenylisoflavone |
CHEMBL393222
|
2 / 1 / 1 | No. 15 | No. 15 |
|
||
|
C00004089
|
6-Prenylapigenin
/ 6-C-Prenylapigenin / 5,7,4'-Trihydroxy-6-prenylflavone / 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one |
No. 15 | No. 15 |
|
||||
|
C00002562
|
Pomiferin
|
CHEMBL393136
|
37 / 43 / 61 | No. 18 | No. 15 |
|
||
|
C00002961
|
Macluraxanthone
/ 3-Hydroxyblancoxanthone |
CHEMBL478960
|
5 / 11 / 11 | No. 18 | No. 15 |
|
||
|
C00002555
|
Osajin
|
CHEMBL238188
|
36 / 50 / 70 | No. 18 | No. 15 |
|
||
|
C00008467
|
Lespedezaflavanone D
/ Euchrestaflavanone B |
No. 19 | No. 14 |
|
||||
|
C00004053
|
Cycloartocarpesin
/ 8-(2,4-Dihydroxyphenyl)-5-hydroxy-2,2-dimethyl-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-one |
CHEMBL221908
|
2 / 0 / 0 | No. 24 | No. 15 |
|
||
|
C00013432
|
Carpachromene
/ 5,4'-Dihidroxy-6'',6''-dimethylpyrano[2'',3'':7,6]flavone / 5-Hydroxy-8-(4-hydroxyphenyl)-2,2-dimethyl-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-one |
No. 24 | No. 15 |
|
||||
|
C00011125
|
Osajaxanthone
|
No. 24 | No. 15 |
|
||||
|
C00032369
|
Toxyloxanthone B
|
CHEMBL482997
|
No. 24 | No. 15 |
|
|||
|
C00008331
|
Euchrestaflavanone C
|
No. 39 |
|
|||||
|
C00008570
|
Dihydromorin
|
CHEMBL465073
CHEMBL463453 |
3 / 2 / 5 | No. 42 | No. 14 |
|
||
|
C00011128
|
8-Prenylxanthone
|
No. 47 | No. 15 |
|
||||
|
C00011126
|
Alvaxanthone
|
CHEMBL478937
|
No. 47 | No. 15 |
|
|||
|
C00002968
|
Norathyriol
/ 1,3,6,7-Tetrahydroxyxanthoene |
CHEMBL187265
|
C069053
|
9 / 10 / 7 | 4 / 0 | No. 71 | No. 15 |
|
|
C00019067
|
5,4'-Dihydroxy-5''-(1-hydroxy-1-methylethyl)-4''-methoxyfurano[2'',3'':7,6]isoflavone
|
No. 139 |
|
|||||
|
C00019066
|
5,4'-Dihydroxy-2''-(1-hydroxy-1-methylethyl)-3''-methoxyfurano[4'',5'':6,7]isoflavone
|
No. 139 |
|
|||||
|
C00002893
|
Oxyresveratrol
/ 2,3,4,5'-Tetrahydroxystilbene |
CHEMBL43065
|
20 / 32 / 49 | No. 295 | No. 13 |
|
||
|
C00013405
|
Dinklagin C
/ (+)-5,7-Dihydroxy-6-(2-hydroxy-3-methyl-3-butenyl)-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
No. 984 |
|
|||||
|
C00019068
|
Laburnetin
/ 5,7,4',2''-Tetrahydroxy-6-[3''-methyl-3''-butenyl]isoflavone |
No. 984 |
|
|||||
|
C00011092
|
Toxyloxanthone C
|
CHEMBL459022
|
8 / 4 / 2 | No. 1835 |
|
Human Protein / Gene in interactions
71 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002555 C00002562 C00002893 C00011092 | 1 / 1 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00002555 C00002562 C00002893 C00011092 | 0 / 0 |
| O00255 | Menin | Unclassified protein | C00002555 C00002562 C00002961 | 2 / 5 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00002555 C00002562 C00002961 | 4 / 1 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002555 C00002562 C00002961 | 1 / 2 |
| Q99700 | Ataxin-2 | Unclassified protein | C00002555 C00002562 C00011092 | 1 / 1 |
| O75496 | Geminin | Unclassified protein | C00002555 C00002562 C00011092 | 0 / 0 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002555 C00002562 C00002893 | 7 / 37 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002555 C00002562 C00002893 | 1 / 0 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002555 C00002562 C00011092 | 2 / 0 |
| P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002555 C00002562 C00002893 | 4 / 2 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002555 C00002562 C00002893 | 2 / 2 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002555 C00002562 C00011092 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00002555 C00002562 C00002961 | 4 / 3 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002555 C00002562 | 0 / 0 |
| P37840 | Alpha-synuclein | Unclassified protein | C00002562 C00002893 | 4 / 2 |
| P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | C00002562 C00011092 | 0 / 0 |
| P08254 | Stromelysin-1 | M10A | C00002893 C00002968 | 1 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00002555 C00002562 | 0 / 0 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00002555 C00002562 | 0 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002893 C00008570 | 0 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002555 C00002562 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00002893 C00002968 | 2 / 2 |
| P39900 | Macrophage metalloelastase | M10A | C00002893 C00002968 | 0 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002555 C00002562 | 0 / 1 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002555 C00002562 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002562 C00002961 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002893 C00008570 | 0 / 3 |
| P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00002555 C00002562 | 0 / 3 |
| P08253 | 72 kDa type IV collagenase | M10A | C00002893 C00002968 | 1 / 3 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002562 C00002893 | 0 / 0 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002555 C00002562 | 0 / 0 |
| P03956 | Interstitial collagenase | M10A | C00002893 C00002968 | 0 / 1 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00002555 C00002562 | 0 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00002555 C00002562 | 1 / 1 |
| P45452 | Collagenase 3 | M10A | C00002893 C00002968 | 1 / 1 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002562 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002555 | 0 / 0 |
| P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00008570 | 2 / 2 |
| P14679 | Tyrosinase | Oxidoreductase | C00002893 | 4 / 2 |
| Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00002893 | 4 / 4 |
| P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002555 | 0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00002562 | 7 / 3 |
| O75908 | Sterol O-acyltransferase 2 | Enzyme | C00004053 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00002586 | 0 / 1 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002893 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00002586 | 1 / 1 |
| P12821 | Angiotensin-converting enzyme | M2 | C00002968 | 4 / 2 |
| P42858 | Huntingtin | Unclassified protein | C00002555 | 1 / 1 |
| P55210 | Caspase-7 | C14 | C00002562 | 0 / 0 |
| P31749 | RAC-alpha serine/threonine-protein kinase | Akt | C00004025 | 4 / 1 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002562 | 1 / 1 |
| P39748 | Flap endonuclease 1 | Enzyme | C00002562 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00002562 | 0 / 0 |
| Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00002555 | 1 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00002562 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002555 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002562 | 0 / 1 |
| P49327 | Fatty acid synthase | Transferase | C00002968 | 0 / 0 |
| P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00002893 | 0 / 0 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002968 | 1 / 1 |
| P02545 | Prelamin-A/C | Unclassified protein | C00002555 | 11 / 10 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002555 | 1 / 1 |
| O00167 | Eyes absent homolog 2 | Enzyme | C00002555 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002555 | 0 / 0 |
| P04062 | Glucosylceramidase | Enzyme | C00002555 | 6 / 4 |
| Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00011092 | 0 / 0 |
| P06746 | DNA polymerase beta | Enzyme | C00002555 | 0 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002555 | 0 / 0 |
| P35610 | Sterol O-acyltransferase 1 | Enzyme | C00004053 | 0 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002562 | 1 / 0 |
4 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002968
|
| 5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00002968
|
| 5467 | PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB | peroxisome proliferator-activated receptor delta |
C00002968
|
| 5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00002968
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (85)
| OMIM | preferred title | UniProt |
|---|---|---|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #613546 | Aromatase deficiency |
P11511
|
| #139300 | Aromatase excess syndrome; aexs |
P11511
|
| #608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #114480 | Breast cancer |
P31749
P38398 |
| #604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #114500 | Colorectal cancer; crc |
P31749
P84022 |
| #614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
| #615109 | Cowden syndrome 6; cws6 |
P31749
|
| #127750 | Dementia, lewy body; dlb |
P37840
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #133239 | Esophageal cancer |
P04637
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
| #231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
| #137760 | Glaucoma, primary open angle; poag |
Q16678
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #614519 | Hemorrhage, intracerebral, susceptibility to; ich |
P12821
|
| #143100 | Huntington disease; hd |
P42858
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #211980 | Lung cancer |
P04637
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #612624 | Microvascular complications of diabetes, susceptibility to, 3; mvcd3 |
P12821
|
| #259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #167000 | Ovarian cancer |
P38398
|
| #614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
| #605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
P37840 |
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #604229 | Peters anomaly |
Q16678
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #176920 | Proteus syndrome |
P31749
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #267430 | Renal tubular dysgenesis; rtd |
P12821
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #601367 | Stroke, ischemic |
P12821
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG DISEASE (89)
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
| H00082 | Graves' disease |
P01215
(marker)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) Q92731 (marker) |
| H00028 | Choriocarcinoma |
P03956
(related)
P04637 (related) P08253 (related) |
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
P37840 (related) |
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
| H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P04637
(related)
|
| H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00022 | Bladder cancer |
P04637
(related)
|
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
| H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
| H00032 | Thyroid cancer |
P04637
(related)
|
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00042 | Glioma |
P04637
(related)
P04637 (marker) |
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00046 | Cholangiocarcinoma |
P04637
(related)
P35354 (related) |
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00472 | Torg-Winchester syndrome |
P08253
(related)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P11511
(related)
|
| H00794 | Aromatase excess syndrome |
P11511
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00083 | Allograft rejection |
P12821
(related)
|
| H00575 | Renal tubular dysgenesis |
P12821
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00057 | Parkinson's disease (PD) |
P37840
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00612 | Primary open angle glaucoma |
Q16678
(related)
|
| H01075 | Peters anomaly |
Q16678
(related)
|
| H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
| H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|